Cambridge Consultants Introduces Vortik Design For Liquid Spray Systems - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Cambridge Consultants Introduces Vortik Design For Liquid Spray Systems
Cyclonic-spray technology improves spray consistency and allows mixing at the point of delivery.

Equipment and Processing Report

Product development firm Cambridge Consultants introduced its Vortik technology that allows different liquids to be mixed at the point of spray without altering the spray characteristics. Pharmaceutical applications could include tablet coating and drug delivery outside of the respirable range (e.g., dermatological cream or nasal or buccal application).

Conventional atomizers use either high pressure or high airflow to create a spray. This new fluid handling technology combines low-pressure air and liquid in a specially shaped cyclone chamber. Shear between swirling air and the liquids creates the desired droplet size for spraying.

Allowing active ingredients to be mixed at the point of delivery overcomes shelf-life and stability issues. The technology provides consistent spray quality and tighter control of concentration and particle size.

Source: Cambridge Consultants


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Equipment and Processing Report,
Click here